Emergence of carbapenem-resistant Acinetobacter baumannii harboring the OXA-23 carbapenemase in intensive care units of Egyptian hospitals

International Journal of Infectious Diseases

Volumn 17, Issue 12, 2013, Pages

  Fouad, Mahmoud ^a   Attia, Ahmed S ^b   Tawakkol, Wael M ^a,b   Hashem, Abdelgawad M ^b  

^a Misr University for Science and Technology   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Acinetobacter baumannii; Carbapenem resistance; Egypt; OXA 23 carbapenemase

Indexed keywords

BACTERIAL ENZYME; BETA LACTAMASE OXA 23; BETA LACTAMASE OXA 51; CARBAPENEM; CARBAPENEMASE; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; INTEGRASE; INTEGRASE 1; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; DISK DIFFUSION; EGYPT; ENTEROBACTER; ENTEROBACTERIAL REPETITIVE INTERGENIC CONSENSUS; ESCHERICHIA COLI; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA; MAJOR CLINICAL STUDY; MENINGITIS; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PROTEUS; PSEUDOMONAS; WOUND INFECTION;

ACINETOBACTER BAUMANNII; CARBAPENEM RESISTANCE; EGYPT; OXA-23 CARBAPENEMASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CLUSTER ANALYSIS; CROSS INFECTION; EGYPT; HUMANS; INTENSIVE CARE UNITS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR TYPING;

EID: 84888428392     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.07.012     Document Type: Article

References (10)

1. Maslow J.N., Glaze T., Adams P., Lataillade M. Concurrent outbreak of multidrug-resistant and susceptible subclones of Acinetobacter baumannii affecting different wards of a single hospital. Infect Control Hosp Epidemiol 2005, 26:69-75.
2. Rodloff A.C., Goldstein E.J., Torres A. Two decades of imipenem therapy. J Antimicrob Chemother 2006, 58:916-929.
3. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement M100-S19 2009, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA.
4. Durante-Mangoni E., Zarrilli R. Global spread of drug-resistant Acinetobacter baumannii: molecular epidemiology and management of antimicrobial resistance. Future Microbiol 2011, 6:407-422.
5. Al-Hassan L., El Mehallawy H., Amyes S.G. Diversity in Acinetobacter baumannii isolates from paediatric cancer patients in Egypt. Clin Microbiol Infect 2013.
6. Kaase M., Nordmann P., Wichelhaus T.A., Gatermann S.G., Bonnin R.A., Poirel L. NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother 2011, 66:1260-1262.
7. Peleg A.Y., Seifert H., Paterson D.L. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 2008, 21:538-582.
8. Koeleman J.G., Stoof J., Van Der Bijl M.W., Vandenbroucke-Grauls C.M., Savelkoul P.H. Identification of epidemic strains of Acinetobacter baumannii by integrase gene PCR. J Clin Microbiol 2001, 39:8-13.
9. Medina-Presentado J.C., Seija V., Vignoli R., Pontet J., Robino L., Cordeiro N.F., et al. Polyclonal endemicity of Acinetobacter baumannii in ventilated patients in an intensive care unit in Uruguay. Int J Infect Dis 2013, 17:e422-e427.
10. Liu P.Y., Wu W.L. Use of different PCR-based DNA fingerprinting techniques and pulsed-field gel electrophoresis to investigate the epidemiology of Acinetobacter calcoaceticus-Acinetobacter baumannii complex. Diagn Microbiol Infect Dis 1997, 29:19-28.